Accordingly, we discuss whether targeting of IL-1/IL-1 receptor (IL-1R) and/or tumor-supporting M2-type macrophages will offer useful therapeutic strategies for inhibition of tumor growth and lymph node metastasis, through suppression of lymphangiogenesis and angiogenesis by lung cancer cells. The gene discussed is IL1R1; the disease is lung cancer.